Boom-Boom Radiation as Bridging Therapy Prior to CAR-T for DLBCL | Christopher D'Angelo, MD | #ASH24
Boom-Boom Radiation as Bridging Therapy Prior to CAR-T for DLBCL | Christopher D'Angelo, MD | #ASH24Подробнее
CAR-T Therapy for DLBCLПодробнее
The value of CAR-T cell therapy in R/R DLBCLПодробнее
CAR T-Cell Therapy in DLBCLПодробнее
Exploring Targeted and CAR T-Cell Therapies on the Horizon for MCLПодробнее
CAR-T Therapies in Antiphospholipid Antibody SyndromeПодробнее
Clinical indications for CAR-T therapy in DLBCL & the possibility of moving CAR-T into earlier linesПодробнее
New algorithm for second-line DLBCL: the role of CAR-T therapyПодробнее
BASECAMP-1: progress in developing CAR-T cell therapy for solid tumorsПодробнее
Phase I study of CD22-targeted CAR-T therapy in patients with CD19-negative B-ALLПодробнее
CAR-T therapy in R/R DLBCLПодробнее
Novel therapeutic approaches in glioblastoma: CAR-T therapy & BBB modulationПодробнее
Dr. John Bell describing CAR-T cell therapyПодробнее
The challenges of CAR T-cell therapy for pediatric B-ALLПодробнее
CAR-T cell therapy DLBCL landscapeПодробнее
Lymphodepletion for CAR T-Cell Therapies in DLBCLПодробнее
CAR-T for ALL: bridging options and choicesПодробнее
Optimal lymphodepletion in CAR-T therapy recipientsПодробнее
The role of CAR T-cell therapy in DLBCLПодробнее
